Zinc supplementation augments the suppressive effects of repurposed NF-κB inhibitors on ACE2 expression in human lung cell lines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zinc supplementation augments the suppressive effects of repurposed NF-κB inhibitors on ACE2 expression in human lung cell lines
Authors
Keywords
ACE2, NF-kappa B, ROS, Triclabendazole, Emetine, Zinc
Journal
LIFE SCIENCES
Volume 280, Issue -, Pages 119752
Publisher
Elsevier BV
Online
2021-06-23
DOI
10.1016/j.lfs.2021.119752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats
- (2020) Tomoyuki Furubayashi et al. Pharmaceutics
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
- (2020) Jennifer A. Aguiar et al. EUROPEAN RESPIRATORY JOURNAL
- The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
- (2020) Inga Wessels et al. Frontiers in Immunology
- NF-κB inhibitors in treatment and prevention of lung cancer
- (2020) Rajan Radha Rasmi et al. BIOMEDICINE & PHARMACOTHERAPY
- Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
- (2020) Nehla Banu et al. LIFE SCIENCES
- Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
- (2020) Claudia Guadalupe Benítez-Cardoza et al. LIFE SCIENCES
- Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
- (2020) Abhjieet Pandey et al. LIFE SCIENCES
- The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
- (2020) Tapan Behl et al. LIFE SCIENCES
- Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions
- (2020) Abdollah Jafarzadeh et al. LIFE SCIENCES
- Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
- (2020) Hongpeng Jia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
- (2020) Mart M Lamers et al. EMBO JOURNAL
- Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
- (2020) Jiayu Lu et al. LIFE SCIENCES
- Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension
- (2019) Mohammad AbdulHai Siddique et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Angiotensin-Converting Enzyme 2/Angiotensin (1–7)/Mas Axis Protects Against Lung Fibroblast Migration and Lung Fibrosis by Inhibiting the NOX4-Derived ROS-Mediated RhoA/Rho Kinase Pathway
- (2015) Ying Meng et al. ANTIOXIDANTS & REDOX SIGNALING
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy
- (2012) Zhen Liu et al. LABORATORY INVESTIGATION
- Identifying the regulatory element for human angiotensin-converting enzyme 2 (ACE2) expression in human cardiofibroblasts
- (2011) Tang-Ching Kuan et al. PEPTIDES
- Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action
- (2010) Susanne C. Miller et al. BIOCHEMICAL PHARMACOLOGY
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- (2010) Aartjan J. W. te Velthuis et al. PLoS Pathogens
- Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
- (2009) Shizuko Sei et al. Molecular Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search